LAUSANNE, Switzerland – Saphetor S.A. is proud to report that its entry in the recent “Precision FDA” contest, organised by the Food and Drug Administration, met with resounding success.
It received top marks in the main challenge, and it was steadily in the top ranks in all metrics, as in previous Precision FDA contests.
The purpose of these contests is to “support the community’s efforts in developing advanced genomic analysis technologies that use next-generation sequencing (NGS) –specifically NGS bioinformatics. Participation is voluntary, but instrumental in helping the community prepare for the coming genomic data revolution.”
This result is a testament of the total commitment of the Saphetor team towards excellence, and in meeting the promise to its customers to deliver the best possible quality in support of their important mission.